A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.


Updates from The Motley Fool

Latest updates on NxStage Medical from Fool.com.  The Fool has written over 100 articles on NxStage Medical.


Stock Performance

View Interactive NXTM Charts
Sponsored by

Key Data Points

Primary metrics and data points about NxStage Medical.
Current Price: $27.77
Prev Close: $27.75
Open: $27.75
Bid: $27.05
Ask: $27.95
Day's Range: $27.72 - $27.80
52wk Range: $20.45 - $30.80
Volume: 403,190
Avg Vol 1,434,593
Market Cap: $2B
P/E (ttm): -396.43
EPS (ttm): ($0.07)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NxStage Medical.
CAPS Rating 4 out of 5
 
143 Outperform
33 Underperform
CAPS All Stars
 
33 Outperform
7 Underperform

How do you think NxStage Medical will perform against the market?



You pick for NxStage Medical is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jeff Burbank, CEO

99% Approve

Based on 30 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NxStage Medical.

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT